// App-Quantinova.ai

30 : A randomized controlled trial to determine the effect of triptorelin on reduction of prostate volume preradiotherapy compared with standard therapy (goserelin).

Researchers

Presenter

  • Amit Bahl

Principal Investigators

  • Amarnath Challapalli

  • Susan Masson

  • Serena Hilman

  • Katrina Hurley

  • Rajendra Persad

Medical Centers

  • University Hospitals Bristol NHS Foundation Trust, Wells Somerset, United Kingdom

  • Bristol Haematology and Oncology Centre, Bristol, United Kingdom

  • Bristol Haematology and Oncology Centre, Bristol, United Kingdom

  • University of Bristol, Bristol, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Prostate specific antigen

Drug/Treatment

  • Bicalutamide

  • Triptorelin

  • Goserelin

Outcome

  • N/A

Study Design

  • Randomized

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved